The purpose of this study is to compare the safety and efficacy of letermovir with valganciclovir for prevention of Cytomegalovirus (CMV) viremia in moderate t…

CMV ViremiaHeart Transplant InfectionHeart Transplant Failure and Rejection

~Estimated

~$10 – $6,250

Columbia UniversityNCT07079735

Phase 2

Initial Safety Lead-in Followed by a Phase II Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection (The Breast CMV Study)

This is a phase II trial with an initial safety lead-in evaluating the efficacy, safety, neurocognitive, and quality-of-life outcomes of anti-cytomegalovirus (…

Brain Cancer MetastaticCMV Viremia

~Estimated

~$10 – $6,250

The Methodist Hospital Research InstituteNCT07383649

Phase 4

Letermovir Versus Valganciclovir for 90 Days in CMV Seropositive Kidney Transplant Recipients: Results of a Single-center Experience.

The purpose of this study is to find out whether letermovir can help prevent cytomegalovirus (CMV) infection in kidney transplant recipients who are CMV seropo…

CMV InfectionCMVCMV Viremia+1 more

~Estimated

~$10 – $8,750

Elisabeth KincaideNCT07571135